Advancements and strategies in early disease detection

Medical developments and expert guidance continue to emphasize the importance of early detection for cancer and cardiovascular health. New liquid biopsy technology, such as the Galleri test, can identify signs of over 50 types of cancer by detecting tumor DNA fragments in the bloodstream, potentially diagnosing malignancies before symptoms appear.

In Europe, breast cancer remains a major concern, with approximately 360,000 new cases reported annually, averaging nearly 1,000 new diagnoses every day. While mortality rates have declined over the last two decades due to improved treatments, experts note that lifestyle factors such as physical inactivity, alcohol consumption, and tobacco use remain critical risk factors. Specific warning signs for breast cancer include new lumps, nipple retraction, skin dimpling, changes in shape or size, and unusual nipple discharge.

Oncologists have also reported a concerning trend in oral cancer, noting that younger populations are increasingly affected, whereas the disease previously primarily impacted those aged 50 to 70. Dr. Mirza Markišić highlighted that snus use can increase the risk of oral cancer by 20 times. Early diagnosis is vital for survival; while survival rates can reach 90 to 100 percent in the first two stages, the mortality rate for patients in the third and fourth stages is approximately 60 percent within five years.

Regarding thyroid cancer, cases are frequently discovered incidentally during general health screenings. While many thyroid nodules are benign, high-suspicion malignancies require careful management. Advances in treatment, such as the use of the Da Vinci Xi robot, now allow for more precise surgical interventions with improved aesthetic outcomes compared to traditional open surgery.